SCHEMBL12447413

SCHEMBL12447413

Cc1c(C(=O)Cl)cnn1O

nearest known ligand 0.37

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 2/20 0.37
▸ PTGS2 P35354 1/20 0.36
▸ KDM4E B2RXH2 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ GRIA1 P42261 1/20 0.34
▸ GRIA2 P42262 1/20 0.34
▸ GRIA3 P42263 1/20 0.34
▸ GRIA4 P48058 1/20 0.34
▸ NPC1 O15118 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ SLC9A1 P19634 1/20 0.31
▸ SLC9A2 Q9UBY0 1/20 0.31
▸ KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3050197 0.79 RAB9A (0.49) MAPK1PTGS2KDM4EALDH1A1TDP1
SCHEMBL17995120 0.75 TRPV4 (0.36) MAPK1PTGS2KDM4EALDH1A1TDP1
SCHEMBL22206926 0.72 PTGS2 (0.33) MAPK1PTGS2KDM4EALDH1A1TDP1
SCHEMBL31433034 0.72 MGLL (0.38) —
SCHEMBL6156185 0.71 LMNA (0.37) MAPK1PTGS2ALDH1A1NPC1RAB9A
SCHEMBL3517559 0.71 MAPK1 (0.73) MAPK1PTGS2ALDH1A1NPC1RAB9A
SCHEMBL1420171 0.70 KMT2A (0.58) MAPK1PTGS2ALDH1A1NPC1RAB9A
SCHEMBL13732956 0.70 SPR (0.32) MAPK1PTGS2ALDH1A1SMN1; SMN2
SCHEMBL619113 0.68 HTT (0.36) MAPK1ALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL29284672 0.68 PTGS2 (0.30) MAPK1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2133348-B1 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors BRISTOL MYERS SQUIBB CO (US) 2011-08-31 — — EP disclosed
EP-1618092-B1 ARYL-SUBSTITUTED PYRAZOLE-AMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2010-09-22 — — EP disclosed
Send feedback